A system to select for mutant LLC-PK1 cells affected in camp mediated hormonal response using a photoactivatable analogue of vasopressin

Heike Luzius, David A. Jans, Falk Fahrenholz

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

The photoreactive analogue of vasopressin, [1-(3-mercapto) propionic acid, 8-(N6-4-azidophenyl-amidino)lysine] vasopressin (apa-LVP) could be used to elicit stimulation of cAMP production in LLC-PK renal epithelial cells, detectable up to 24 h after photoacti-vation by flash photolysis. This is in contrast to cells treated with vasopressin, or apa-LVP without photoactivation, where cAMP synthesis is down regulated within 4 h. The prolonged stimulation of cAMP production induced by photoactivation of apa-LVP was demonstrated to be cytotoxic to LLC-PK1 cells, whereas the vasopressin receptor negative LLC-PK1 mutant M18 was resistant to the cytotoxic effect. A selection strategy was developed for mutants resistant to this long-term stimulation of cAMP production, whereby multiple cycles of treatment with apa-LVP and photoactivation were used. Mutants so selected were then characterized using a novel screening system for detection of the production of urokinase-type plasminogen activator in response to cAMP agonists. One mutant was examined and found to be impaired in hormonal responsiveness, whereby hormone and forskolin stimulated cAMP-mediated responses were markedly reduced. It exhibited resistance to the long-term stimulation of cAMP production elicited by apa-LVP and photoactivation. This implies that apa-LVP can be used to select for novel mutants specifically impaired in cAMP metabolism and in particular down-regulation of cAMP response.

Original languageEnglish
Pages (from-to)61-80
Number of pages20
JournalJournal of Receptors and Signal Transduction
Volume10
Issue number1-2
DOIs
Publication statusPublished - 1 Jan 1990
Externally publishedYes

Cite this

@article{21c43e40977548ac819dcbd457033b4e,
title = "A system to select for mutant LLC-PK1 cells affected in camp mediated hormonal response using a photoactivatable analogue of vasopressin",
abstract = "The photoreactive analogue of vasopressin, [1-(3-mercapto) propionic acid, 8-(N6-4-azidophenyl-amidino)lysine] vasopressin (apa-LVP) could be used to elicit stimulation of cAMP production in LLC-PK renal epithelial cells, detectable up to 24 h after photoacti-vation by flash photolysis. This is in contrast to cells treated with vasopressin, or apa-LVP without photoactivation, where cAMP synthesis is down regulated within 4 h. The prolonged stimulation of cAMP production induced by photoactivation of apa-LVP was demonstrated to be cytotoxic to LLC-PK1 cells, whereas the vasopressin receptor negative LLC-PK1 mutant M18 was resistant to the cytotoxic effect. A selection strategy was developed for mutants resistant to this long-term stimulation of cAMP production, whereby multiple cycles of treatment with apa-LVP and photoactivation were used. Mutants so selected were then characterized using a novel screening system for detection of the production of urokinase-type plasminogen activator in response to cAMP agonists. One mutant was examined and found to be impaired in hormonal responsiveness, whereby hormone and forskolin stimulated cAMP-mediated responses were markedly reduced. It exhibited resistance to the long-term stimulation of cAMP production elicited by apa-LVP and photoactivation. This implies that apa-LVP can be used to select for novel mutants specifically impaired in cAMP metabolism and in particular down-regulation of cAMP response.",
author = "Heike Luzius and Jans, {David A.} and Falk Fahrenholz",
year = "1990",
month = "1",
day = "1",
doi = "10.3109/10799899009064658",
language = "English",
volume = "10",
pages = "61--80",
journal = "Journal of Receptor and Signal Transduction",
issn = "1079-9893",
publisher = "Taylor & Francis",
number = "1-2",

}

A system to select for mutant LLC-PK1 cells affected in camp mediated hormonal response using a photoactivatable analogue of vasopressin. / Luzius, Heike; Jans, David A.; Fahrenholz, Falk.

In: Journal of Receptors and Signal Transduction, Vol. 10, No. 1-2, 01.01.1990, p. 61-80.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A system to select for mutant LLC-PK1 cells affected in camp mediated hormonal response using a photoactivatable analogue of vasopressin

AU - Luzius, Heike

AU - Jans, David A.

AU - Fahrenholz, Falk

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The photoreactive analogue of vasopressin, [1-(3-mercapto) propionic acid, 8-(N6-4-azidophenyl-amidino)lysine] vasopressin (apa-LVP) could be used to elicit stimulation of cAMP production in LLC-PK renal epithelial cells, detectable up to 24 h after photoacti-vation by flash photolysis. This is in contrast to cells treated with vasopressin, or apa-LVP without photoactivation, where cAMP synthesis is down regulated within 4 h. The prolonged stimulation of cAMP production induced by photoactivation of apa-LVP was demonstrated to be cytotoxic to LLC-PK1 cells, whereas the vasopressin receptor negative LLC-PK1 mutant M18 was resistant to the cytotoxic effect. A selection strategy was developed for mutants resistant to this long-term stimulation of cAMP production, whereby multiple cycles of treatment with apa-LVP and photoactivation were used. Mutants so selected were then characterized using a novel screening system for detection of the production of urokinase-type plasminogen activator in response to cAMP agonists. One mutant was examined and found to be impaired in hormonal responsiveness, whereby hormone and forskolin stimulated cAMP-mediated responses were markedly reduced. It exhibited resistance to the long-term stimulation of cAMP production elicited by apa-LVP and photoactivation. This implies that apa-LVP can be used to select for novel mutants specifically impaired in cAMP metabolism and in particular down-regulation of cAMP response.

AB - The photoreactive analogue of vasopressin, [1-(3-mercapto) propionic acid, 8-(N6-4-azidophenyl-amidino)lysine] vasopressin (apa-LVP) could be used to elicit stimulation of cAMP production in LLC-PK renal epithelial cells, detectable up to 24 h after photoacti-vation by flash photolysis. This is in contrast to cells treated with vasopressin, or apa-LVP without photoactivation, where cAMP synthesis is down regulated within 4 h. The prolonged stimulation of cAMP production induced by photoactivation of apa-LVP was demonstrated to be cytotoxic to LLC-PK1 cells, whereas the vasopressin receptor negative LLC-PK1 mutant M18 was resistant to the cytotoxic effect. A selection strategy was developed for mutants resistant to this long-term stimulation of cAMP production, whereby multiple cycles of treatment with apa-LVP and photoactivation were used. Mutants so selected were then characterized using a novel screening system for detection of the production of urokinase-type plasminogen activator in response to cAMP agonists. One mutant was examined and found to be impaired in hormonal responsiveness, whereby hormone and forskolin stimulated cAMP-mediated responses were markedly reduced. It exhibited resistance to the long-term stimulation of cAMP production elicited by apa-LVP and photoactivation. This implies that apa-LVP can be used to select for novel mutants specifically impaired in cAMP metabolism and in particular down-regulation of cAMP response.

UR - http://www.scopus.com/inward/record.url?scp=0024997711&partnerID=8YFLogxK

U2 - 10.3109/10799899009064658

DO - 10.3109/10799899009064658

M3 - Article

C2 - 2175811

AN - SCOPUS:0024997711

VL - 10

SP - 61

EP - 80

JO - Journal of Receptor and Signal Transduction

JF - Journal of Receptor and Signal Transduction

SN - 1079-9893

IS - 1-2

ER -